Sublime

Tackling the future $Trillion dollar germline gene correction industry. Imagine billions of people born without inherited disease. Science should help patients. Ethics should be determined by the people. Transparency matters. Honored to work with world-class scientists and visionary... See more

@vasudevbailey @brandonhli @johnprendergass @Jack_O_Meara @marcjlajoie @jack @sharpshoot @annalisaJenkin4 @SynBioMars @charleskfisher @heyjudka For #AAV #GeneTherapy I love alot of the research coming out of The Ohio State Uni, UNC Chapel Hill, U Florida, Duke

I see this exact same story playing out with RNA-based medicines, led by ASO and siRNA. Very exciting for patients, innovation, and science!

Everything you need to know about $ABCL, the $PLTR of biotech, in just 9 bullet points: 1. $ABCL is building an antibody platform with the capability to address any human bodily disorder and the company seems to be very well managed. By getting good at producing antibodies with a specific function, $ABCL is getting good... See more

It is not a secret that roughly 4 years ago, I resigned my faculty position @UCSF and closed my lab to go to @ThirdRockV to work on a new company concept. This was not a spur of the moment or rash decision but it was made easier by the fact that the new idea was something motivated and inspired by my friend and mentor, Charles Homcy. The group at... See more